| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79d94c2f80175a5710dc001f351e0c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279613901b2b93755a174d9e16b4b7c9 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate |
1999-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d92abb640697f1aa6694c7c6af57d685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c27d5928b65f4372f4773b2a03932e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6357c449cf3dce97da278320dbff8b20 |
| publicationDate |
2001-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2165254-C2 |
| titleOfInvention |
Pharmaceutical composition for treatment of viral diseases |
| abstract |
FIELD: pharmaceutical industry. SUBSTANCE: composition contains 0.004-0.040 g 2- benzimidazol hydrochloride, 0.025-0.100 g ascorbic acid, and 0.0005-0.005 g L-glutamyl-L-tryptophan monosodium salt as immunomodulating component per 1 dosed therapeutic unit. EFFECT: simplified administration and increased efficiency in treatment of diseases caused by interferon-sensitive viruses. 6 dwg, 2 tbl, 3 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013055251-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012087181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445965-C2 |
| priorityDate |
1999-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |